| scholarly article | Q13442814 |
| P356 | DOI | 10.1136/JECH.2005.038505 |
| P8608 | Fatcat ID | release_4odtq53ngjd5rafgieqxd7vonu |
| P932 | PMC publication ID | 2465597 |
| P698 | PubMed publication ID | 17183014 |
| P5875 | ResearchGate publication ID | 6617443 |
| P50 | author | Roberto Elosua | Q32650731 |
| Jaume Marrugat | Q46022966 | ||
| Joan Gené-Badia | Q54877962 | ||
| Ralph B. D'Agostino Sr. | Q59209521 | ||
| P2093 | author name string | Isaac Subirana | |
| Joan Vila | |||
| Byung-Ho Nam | |||
| Rafel Ramos | |||
| Joan Sala | |||
| Carmen Cabezas | |||
| Eva Comín | |||
| Ferran Cordón | |||
| Pascual Solanas | |||
| VERIFICA Investigators | |||
| P2860 | cites work | Prediction of Coronary Heart Disease Using Risk Factor Categories | Q22241923 |
| Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study | Q24630111 | ||
| Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) | Q27860959 | ||
| Statins for primary prevention: at what coronary risk is safety assured? | Q28362569 | ||
| Mortality by cause for eight regions of the world: Global Burden of Disease Study | Q29615121 | ||
| Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction | Q29618673 | ||
| A cross-validation of risk-scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study | Q30713072 | ||
| Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies | Q33609042 | ||
| Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials | Q34065021 | ||
| Differences in coronary mortality can be explained by differences in cholesterol and saturated fat intakes in 40 countries but not in France and Finland. A paradox | Q34728807 | ||
| An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas | Q35412825 | ||
| High prevalence of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence. REGICOR Investigators. | Q35558039 | ||
| Coronary heart disease incidence in northern and southern European populations: a reanalysis of the seven countries study for a European coronary risk chart | Q35567095 | ||
| Paying for statins | Q36147834 | ||
| Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation | Q43742848 | ||
| Coronary risk estimation in Spain using a calibrated Framingham function | Q44352908 | ||
| Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study | Q44918035 | ||
| Concept and usefulness of cardiovascular risk profiles | Q44950857 | ||
| Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study | Q47198345 | ||
| The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group | Q47690865 | ||
| European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice | Q49154329 | ||
| Acute myocardial infarction case fatality, incidence and mortality rates in a population registry in Gerona, Spain, 1990-1992. REGICOR Investigators. | Q50864128 | ||
| Regional variability in population acute myocardial infarction cumulative incidence and mortality rates in Spain 1997 and 1998. | Q51985889 | ||
| Framingham risk function overestimates risk of coronary heart disease in men and women from Germany—results from the MONICA Augsburg and the PROCAM cohorts | Q52017724 | ||
| Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study. | Q52082107 | ||
| [Comparison of population coronary heart disease risk estimated by the Framingham original and REGICOR calibrated functions] | Q57235956 | ||
| [Epidemiology of ischaemic heart disease in Spain: estimation of the number of cases and trends from 1997 to 2005] | Q57236010 | ||
| Cardiovascular Events in Diabetic and Nondiabetic Adults With or Without History of Myocardial Infarction | Q57306775 | ||
| P433 | issue | 1 | |
| P921 | main subject | circulatory system | Q11068 |
| P304 | page(s) | 40-47 | |
| P577 | publication date | 2007-01-01 | |
| P1433 | published in | Journal of Epidemiology and Community Health | Q3428712 |
| P1476 | title | Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA Study | |
| P478 | volume | 61 |
| Q87414143 | Q87414143 |
| Q46101552 | A Cross-sectional Study to Estimate Cardiovascular Risk Factors in Patients with Bipolar Disorder |
| Q38381804 | A Pilot Study to Assess the Feasibility of the Spanish Diabetes Self-Management Program in the Basque Country. |
| Q51374764 | A short screener is valid for assessing Mediterranean diet adherence among older Spanish men and women. |
| Q43286304 | Adaptation of the Framingham-Wilson coronary risk equation for the population of Navarra (RICORNA). |
| Q56243541 | Advanced glycation end products (AGEs) estimated by skin autofluorescence are related with cardiovascular risk in renal transplant |
| Q34755293 | Body adiposity index and cardiovascular health risk factors in Caucasians: a comparison with the body mass index and others. |
| Q57235880 | Capacidad predictiva de las funciones de riesgo cardiovascular: limitaciones y oportunidades |
| Q56504913 | Cardiovascular Risk Factors. Insights From Framingham Heart Study |
| Q33726320 | Cardiovascular risk estimated after 13 years of follow-up in a low-incidence Mediterranean region with high-prevalence of cardiovascular risk factors |
| Q43462118 | Cardiovascular risk factors, cardiovascular risk and quality of life in patients with a severe mental disorder |
| Q42628823 | Cardiovascular risk tables: opinion and degree of use of primary care doctors from Madrid, Spain |
| Q94564976 | Comparative performance of pooled cohort equations and Framingham risk scores in cardiovascular disease risk classification in a slum setting in Nairobi Kenya |
| Q35805646 | Comparison of different vascular risk engines in the identification of type 2 diabetes patients with high cardiovascular risk. |
| Q44221813 | Comparison of the SCORE and Framingham-REGICOR functions for cardiovascular risk assesment |
| Q48235029 | Contribution of the ankle-brachial index to improve the prediction of coronary risk: The ARTPER cohort. |
| Q57235766 | Derivation and validation of a set of 10-year cardiovascular risk predictive functions in Spain: The FRESCO Study |
| Q49043410 | Design and methodology of POWER, an open-label observation of the effect of primary care interventions on total cardiovascular risk in patients with hypertension |
| Q58694922 | Detection of high cardiovascular risk patients with ankylosing spondylitis based on the assessment of abdominal aortic calcium as compared to carotid ultrasound |
| Q37111718 | Development of appropriate coronary heart disease risk prediction models in HIV-infected patients. |
| Q35918503 | Diagnostic inertia in dyslipidaemia: results of a preventative programme in Spain |
| Q34702818 | Dietary habits in patients with ischemic stroke: a case-control study. |
| Q51804412 | Estimating the risk of peripheral artery disease using different population strategies. |
| Q36032312 | Estimation of 10-Year Risk of Coronary Heart Disease in Nepalese Patients with Type 2 Diabetes: Framingham Versus United Kingdom Prospective Diabetes Study |
| Q31139249 | Framingham risk score for prediction of cardiovascular diseases: a population-based study from southern Europe. |
| Q47657268 | Framingham-Based Cardiovascular Risk Estimates Among People With Episodic Migraine in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study |
| Q34746829 | Impact of a self-care education programme on patients with type 2 diabetes in primary care in the Basque Country |
| Q50446755 | Impact of tacrolimus and mycophenolate mofetil regimen vs. a conventional therapy with steroids on cardiovascular risk in liver transplant patients. |
| Q31033555 | Improving interMediAte risk management. MARK study |
| Q37366209 | Investigating silent strokes in hypertensives: a magnetic resonance imaging study (ISSYS): rationale and protocol design. |
| Q59708030 | La función calibrada REGICOR mejora la clasificación de los pacientes de alto riesgo tratados con estatinas respecto a Framingham y SCORE en la población española |
| Q35259627 | Original and REGICOR Framingham functions in a nondiabetic population of a Spanish health care center: a validation study |
| Q36241155 | Performance of the Framingham and SCORE cardiovascular risk prediction functions in a non-diabetic population of a Spanish health care centre: a validation study |
| Q92688203 | Performance of the Framingham risk models and pooled cohort equations for predicting 10-year risk of cardiovascular disease: a systematic review and meta-analysis |
| Q38842834 | Physical activity prescription by primary care nurses using health assets: Study design of a randomized controlled trial in patients with cardiovascular risk factors. |
| Q54459850 | Population prevalence and control of cardiovascular risk factors: what electronic medical records tell us. |
| Q51583909 | Predicting CHD risk in France: a pooled analysis of the D.E.S.I.R., Three City, PRIME, and SU.VI.MAX studies. |
| Q51581899 | Predicting the onset of major depression in primary care: international validation of a risk prediction algorithm from Spain. |
| Q35187760 | Prediction of cardiovascular disease risk among low-income urban dwellers in metropolitan Kuala Lumpur, Malaysia |
| Q51604005 | Predictive accuracy of the 'Framingham's general CVD algorithm' in a Middle Eastern population: Tehran Lipid and Glucose Study. |
| Q34759380 | Prevalence of obesity and associated cardiovascular risk: the DARIOS study. |
| Q57235813 | Prevención cardiovascular: avances y el largo camino por recorrer |
| Q34180573 | Randomised clinical trial of an intensive intervention in the primary care setting of patients with high plasma fibrinogen in the primary prevention of cardiovascular disease. |
| Q45206674 | Reflections on cardiovascular risk estimates in primary prevention. |
| Q57235885 | Respuesta |
| Q59708035 | Risk Functions and the Primary Prevention of Cardiovascular Disease |
| Q93075304 | Role of HDL function and LDL atherogenicity on cardiovascular risk: A comprehensive examination |
| Q40707284 | Role of renal function in cardiovascular risk assessment: A retrospective cohort study in a population with low incidence of coronary heart disease. |
| Q37691093 | SCORE and REGICOR function charts underestimate the cardiovascular risk in Spanish patients with rheumatoid arthritis |
| Q31162135 | Screening premorbid metabolic syndrome in community pharmacies: a cross-sectional descriptive study. |
| Q39054698 | Sex-related differences in abdominal obesity impact on ischemic stroke risk. |
| Q36069547 | Short-term predictive ability of selected cardiovascular risk prediction models in a rural Bangladeshi population: a case-cohort study |
| Q45227773 | Statins and new-onset atrial fibrillation in a cohort of patients with hypertension. Analysis of electronic health records, 2006-2015. |
| Q44509968 | Ten-year risk prediction in French men using the Framingham coronary score: results from the national SU.VI.MAX cohort |
| Q61771952 | The HERACLES Cardiovascular Network |
| Q82427008 | The epidemiology of cardiovascular disease in primary care. the Zona Franca Cohort study in Barcelona, Spain |
| Q58587152 | The peripheral atherosclerotic profile in patients with type 1 diabetes mellitus warrants a thorough vascular assessment of asymptomatic patients |
| Q30476450 | The population-based Barcelona-Asymptomatic Intracranial Atherosclerosis Study (ASIA): rationale and design. |
| Q46958892 | Trends in cardiovascular risk factor prevalence (1995-2000-2005) in northeastern Spain |
| Q34901444 | Unanswered clinical questions in the management of cardiometabolic risk in the elderly: a statement of the Spanish Society of Internal Medicine. |
| Q39233353 | Validation of a population coronary disease predictive system: the CASSANDRA model. |
| Q55306767 | Validity of a method for the self-screening of cardiovascular risk. |
| Q80146010 | [Cardiovascular PAPPS 2005: a critical analysis] |
| Q82592377 | [Cardiovascular risk factors and Primary Care: evaluation and intervention] |
| Q81190698 | [Cardiovascular risk factors in chronic obstructive pulmonary disease: results of the ARCE study] |
| Q53145182 | [Differences between MDRD-4 and CG in the prevalence of renal failure and its associated variables in type2 diabetic patients]. |
| Q45990482 | [Evaluation of cardiovascular risk in the cross-sectional phase of the Mediterranean Study]. |
| Q80399774 | [New instruments, same risks] |
| Q80482723 | [Reflections on the updating of 2005 cardiovascular PAPPS] |
| Q81468880 | [Statins on primary prevention: risk, objectives, efficacy, and evidence] |
| Q88983094 | Recomendaciones preventivas cardiovasculares. Actualización PAPPS 2018 |
Search more.